Correlation Between Tsh Biopharmoration and Maxigen Biotech

Can any of the company-specific risk be diversified away by investing in both Tsh Biopharmoration and Maxigen Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tsh Biopharmoration and Maxigen Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between tsh biopharmoration and Maxigen Biotech, you can compare the effects of market volatilities on Tsh Biopharmoration and Maxigen Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tsh Biopharmoration with a short position of Maxigen Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tsh Biopharmoration and Maxigen Biotech.

Diversification Opportunities for Tsh Biopharmoration and Maxigen Biotech

0.02

Correlation Coefficient

Tsh Biopharmoration  Maxigen Biotech

Significant diversification

The 3 months correlation between Tsh and Maxigen is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding tsh biopharmoration and Maxigen Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Maxigen Biotech and Tsh Biopharmoration is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on tsh biopharmoration are associated (or correlated) with Maxigen Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Maxigen Biotech has no effect on the direction of Tsh Biopharmoration i.e., Tsh Biopharmoration and Maxigen Biotech go up and down completely randomly.

Pair Corralation between Tsh Biopharmoration and Maxigen Biotech

Assuming the 90 days trading horizon tsh biopharmoration is expected to under-perform the Maxigen Biotech. But the stock apears to be less risky and, when comparing its historical volatility, tsh biopharmoration is 1.1 times less risky than Maxigen Biotech. The stock trades about -0.19 of its potential returns per unit of risk. The Maxigen Biotech is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest  4,455  in Maxigen Biotech on September 24, 2024 and sell it today you would earn a total of  235.00  from holding Maxigen Biotech or generate 5.27% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

tsh biopharmoration  vs.  Maxigen Biotech

tsh biopharmoration

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in tsh biopharmoration are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Tsh Biopharmoration is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Maxigen Biotech

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Maxigen Biotech are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Maxigen Biotech may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Tsh Biopharmoration and Maxigen Biotech

The main advantage of trading using opposite Tsh Biopharmoration and Maxigen Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tsh Biopharmoration position performs unexpectedly, Maxigen Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Maxigen Biotech will offset losses from the drop in Maxigen Biotech's long position.

The idea behind tsh biopharmoration and Maxigen Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.